Agolet 2.5 Tablet
Agolet 2.5 Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.
Agolet 2.5 Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Agolet 2.5 Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.
Agolet 2.5 Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.
Agolet 2.5 Tablet is used to treat breast cancer in women who have gone through the menopause.
03Uses
Breast cancer
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Agolet 2.5 Tablet may be taken with or without food, but it is better to take it at a fixed time.
05How It Works
Agolet 2.5 Tablet is an aromatase inhibitor. It works by decreasing the amount of estrogen (natural female hormone) produced in the body. This decrease in estrogen can slow down or stop the growth of some breast cancers that need estrogen to grow.
06What If You Miss A Dose?
Q: What if you forget to take Agolet Tablet?
A: If you miss a dose of Agolet 2.5 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.n
07Side Effects
Night sweats
Bone pain
Cough
Shortness of breath
Fatigue
Weight gain
Hot flushes
Edema (swelling)
Flushing (sense of warmth in the face, ears, neck and trunk)
Diaphoresis
Bone fracture
Hypercholesterolemia (high cholesterol)
Joint pain
Back pain
Weakness
Dizziness
Nausea
Osteoporosis
Joint inflammation
08Safety Information
Alcohol:SAFE
Consuming alcohol with Agolet 2.5 Tablet does not cause any harmful side effects.
Pregnancy:UNSAFE
Agolet 2.5 Tablet is highly unsafe to use during pregnancy. Seek your doctor’s advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding:UNSAFE
Agolet 2.5 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving:UNSAFE
Agolet 2.5 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney:SAFE IF PRESCRIBED
Agolet 2.5 Tablet is safe to use in patients with kidney disease. No dose adjustment of Agolet 2.5 Tablet is recommended.However, there is limited information on the use of this medicine in patients with end stage kidney disease. Please consult with your doctor.
Liver:CAUTION
Agolet 2.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Agolet 2.5 Tablet may be needed. Please consult your doctor.
09Drug Tips
You have been prescribed Agolet 2.5 Tablet for the treatment of breast cancer.
It can be taken with or without food.
Do not drive or do anything requiring concentration until you know how Agolet 2.5 Tablet affects you.
It may cause increased sweating and hot flushes. Try to keep cool by wearing light and airy clothes.
Your doctor may monitor your cholesterol level and bone mineral density (BMD) regularly as Agolet 2.5 Tablet can alter their levels.
Do not take Agolet 2.5 Tablet if you are pregnant or breastfeeding
References
Sources and references
Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1762.
Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 786-87.
Letrozole. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 1997 [revised Jan. 2014]. [Accessed 03 Apr. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from: View
National Health Service. Letrozole. [Last Reviewed: 21 Jul 2020]. [Accessed 08 Jul. 2023]. (online) Available from: View
Letrozole [Package Insert]. Mumbai, India: HOPE Lifecare. [Accessed 08 Jul. 2023]. (online) Available from: View
Letrozole [Prescribing Information]. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2020. [Accessed 08 Jul. 2023]. (online) Available from: View
